Abstract
Mass spectrometry (MS) offers the capability to identify, characterize and quantify a target molecule in a complex sample matrix and has developed into a premier analytical tool in drug development science. Through specific MS-based workflows including customized sample preparation, coupling to liquid chromatography and different ionization principles, both qualitative and quantitative analysis of small and large drug compounds can be achieved at an unprecedented sensitivity.
Here, we review the basic principles of MS and tandem MS, including ionization, mass analysis and detection, as well as fragmentation techniques and coupling of MS to chromatographic separation. As the structural integrity of protein drugs during purification, formulation and delivery is of critical importance to ensure drug efficacy and safety, an overview over current approaches for primary and higher-order structure analysis of proteins by mass spectrometry will be given as well as related workflows for quantitative MS analysis. Established “top-down” and “bottom-up” protein analyses with MS will be recapitulated, and the use of emerging technologies such as hydrogen/deuterium exchange mass spectrometry (HDX-MS) for higher-order protein structure analysis will be discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ardrey RE (2003) Liquid chromatography-mass spectrometry: an introduction. Wiley, New York
Armbruster DA, Pry T (2008) Limit of blank, limit of detection and limit of quantitation. Clin Biochem Rev 29(Suppl 1):S49–S52
Armbruster DA, Tillman MD, Hubbs LM (1994) Limit of detection (Lod) limit of quantitation (Loq)—comparison of the empirical and the statistical, methods exemplified with GC-MS assays of abused drugs. Clin Chem 40(7):1233–1238
Bai Y, Milne JS, Mayne L, Englander SW (1993) Primary structure effects on peptide group hydrogen exchange. Proteins 17(1):75–86
Brown RS, Lennon JJ (1995) Sequence-specific fragmentation of matrix-assisted laser-desorbed protein peptide ions. Anal Chem 67(21):3990–3999
Campins-Falco P, Herraez-Hernandez R, Sevillano-Cabeza A (1993) Column-switching techniques for high-performance liquid chromatography of drugs in biological samples. J Chromatogr 619(2):177–190
Chen G, Warrack BM, Goodenough AK, Wei H, Wang-Iverson DB, Tymiak AA (2011) Characterization of protein therapeutics by mass spectrometry: recent developments and future directions. Drug Discov Today 16(1–2):58–64
Cole RB (2010) Electrospray and MALDI mass spectrometry: fundamentals, instrumentation, practicalities, and biological applications. Wiley, Oxford
Corradini E, Klaasse G, Leurs U, Heck AJ, Martin NI, Scholten A (2015) Charting the interactome of PDE3A in human cells using an IBMX based chemical proteomics approach. Mol Biosyst 11(10):2783–2797
Frank R, Hargreaves R (2003) Clinical biomarkers in drug discovery and development. Nat Rev Drug Discov 2(7):566–580
Gjelstad A, Pedersen-Bjergaard S (2013) Challenges and new directions in analytical sample preparation. Anal Bioanal Chem 406:375–376
Glish GL, Vachet RW (2003) The basics of mass spectrometry in the twenty-first century. Nat Rev Drug Discov 2(2):140–150
Hardouin J (2007a) Protein sequence information by matrix-assisted laser desorption/ionization in-source decay mass spectrometry. Mass Spectrom Rev 26(5):672–682
Herman JL, Edge T, Majors RE (2012) Theoretical concepts and applications of turbulent flow chromatography. LCGC North America 30(3):200–214
Hillenkamp F, Peter-Katalini J (2007) MALDI MS: a practical guide to instrumentation, methods and applications. Weinheim, Wiley-VCH; [Chichester : John Wiley [distributor]]
Hoffmann ED, Stroobant V (2007) Mass spectrometry: principles and applications. Wiley, Hoboken, NJ; Chichester: John Wiley [distributor]
Holcapek M, Jirasko R, Lisa M (2012) Recent developments in liquid chromatography-mass spectrometry and related techniques. J Chromatogr A 1259:3–15
Houde D, Engen JR (2013) Conformational analysis of recombinant monoclonal antibodies with hydrogen/deuterium exchange mass spectrometry. Methods Mol Biol 988:269–289
Houde DJ, Berkowitz SA (2015) Biophysical characterization of proteins in developing biopharmaceuticals. D. J. H. A. Berkowitz. Elsevier, Amsterdam
Hunt DF, Coon JJ, Syka JEP, Marto JA (2005). Electron transfer dissociation for biopolymer sequence analysis. US 11079147
Jeffery DA, Bogyo M (2003) Chemical proteomics and its application to drug discovery. Curr Opin Biotechnol 14(1):87–95
Jennings KR (1968) Collision-induced decompositions of aromatic molecular ions. Int J Mass Spectrom Ion Phys 1(3):227–235
Jensen PF, Larraillet V, Schlothauer T, Kettenberger H, Hilger M, Rand KD (2015) Investigating the interaction between the neonatal Fc receptor and monoclonal antibody variants by hydrogen/deuterium exchange mass spectrometry. Mol Cell Proteomics 14(1):148–161
Joyce KB, Jones AE, Scott RJ, Biddlecombe RA, Pleasance S (1998) Determination of the enantiomers of salbutamol and its 4-O-sulphate metabolites in biological matrices by chiral liquid chromatography tandem mass spectrometry. Rapid Commun Mass Spectrom 12(23):1899–1910
Karas M, Bahr U (1990) Laser desorption ionization mass spectrometry of large biomolecules. Trends Anal Chem 9(10):321–325
Koppenaal DW, Barinaga CJ, Denton MB, Sperline RP, Hieftje GM, Schilling GD, Andrade FJ, Barnes JH (2005) MS detectors. Anal Chem 77(21):418A–427A
Korfmacher WA, Palmer CA, Nardo C, Dunn-Meynell K, Grotz D, Cox K, Lin CC, Elicone C, Liu C, Duchoslav E (1999) Development of an automated mass spectrometry system for the quantitative analysis of liver microsomal incubation samples: a tool for rapid screening of new compounds for metabolic stability. Rapid Commun Mass Spectrom 13(10):901–907
Lanucara F, Holman SW, Gray CJ, Eyers CE (2014) The power of ion mobility-mass spectrometry for structural characterization and the study of conformational dynamics. Nat Chem 6(4):281–294
Leurs U, Mistarz UH, Rand KD (2015) Getting to the core of protein pharmaceuticals—comprehensive structure analysis by mass spectrometry. Eur J Pharm Biopharm 93:95–109
Li Y, Shin YG, Yu C, Kosmeder JW, Hirschelman WH, Pezzuto JM, van Breemen RB (2003) Increasing the throughput and productivity of Caco-2 cell permeability assays using liquid chromatography-mass spectrometry: application to resveratrol absorption and metabolism. Comb Chem High Throughput Screen 6(8):757–767
Lim MS, Elenitoba-Johnson KS (2004) Proteomics in pathology research. Lab Invest 84(10):1227–1244
Little TA (2015) Method validation essentials, limit of blank, limit of detection, and limit of quantitation. Biopharm Int 28(4):48–51
Makarov A (2000) Electrostatic axially harmonic orbital trapping: a high-performance technique of mass analysis. Anal Chem 72(6):1156–1162
Marshall AG, Hendrickson CL, Shi SD (2002) Scaling MS plateaus with high-resolution FT-ICRMS. Anal Chem 74(9):252A–259A
Pandit D, Tuske SJ, Coales SJ, E SY, Liu A, Lee JE, Morrow JA, Nemeth JF, Hamuro Y (2012) Mapping of discontinuous conformational epitopes by amide hydrogen/deuterium exchange mass spectrometry and computational docking. J Mol Recognit 25(3):114–124
Payan MD, Li B, Petersen NJ, Jensen H, Hansen SH, Pedersen-Bjergaard S (2013) Nano-electromembrane extraction. Anal Chim Acta 785:60–66
Reynolds A (1961) Dynamics of turbulent vortical flow. Z Angew Math Phys 12(2):149–158
Rix U, Superti-Furga G (2009) Target profiling of small molecules by chemical proteomics. Nat Chem Biol 5(9):616–624
Roepstorff P, Fohlman J (1984) Proposal for a nomenclature for sequence ions in mass spectra of peptides. Biomed Mass Spectrom 11:601
Ryhage R (1964) Use of mass spectrometer as detector+analyzer for effluents emerging from high temperature gas liquid chromatography columns. Anal Chem 36(4):759–764
Siuzdak G (1994) The emergence of mass spectrometry in biochemical research. Proc Natl Acad Sci U S A 91(24):11290–11297
Smith RD, Udseth HR, Loo JA, Wright BW, Ross GA (1989) Sample introduction and separation in capillary electrophoresis, and combination with mass spectrometric detection. Talanta 36(1–2):161–169
Syka JE, Coon JJ, Schroeder MJ, Shabanowitz J, Hunt DF (2004) Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry. Proc Natl Acad Sci U S A 101(26):9528–9533
Tao L, Ackerman M, Wu W, Liu P, Russell R (2011) Characterization of impurities and degradants using mass spectrometry. Wiley, Hoboken
van den Broek I, Niessen WMA, van Dongen WD (2013) Bioanalytical LC–MS/MS of protein-based biopharmaceuticals. J Chromatogr B 929:161–179
Wanner KT, Höfner G (2007) Mass spectrometry in medicinal chemistry. Weinheim, Wiley-VCH; Chichester : John Wiley [distributor]
Zhang Z, Smith DL (1993) Determination of amide hydrogen exchange by mass spectrometry: a new tool for protein structure elucidation. Protein Sci 2(4):522–531
Zheng J (2009) Formulation and analytical development for low-dose oral drug products. Wiley, New York
Zubarev RA, Horn DM, Fridriksson EK, Kelleher NL, Kruger NA, Lewis MA, Carpenter BK, McLafferty FW (2000) Electron capture dissociation for structural characterization of multiply charged protein cations. Anal Chem 72(3):563–573
Zubarev RA, Kruger NA, Fridriksson EK, Lewis MA, Horn DM, Carpenter BK, McLafferty FW (1999) Electron capture dissociation of gaseous multiply-charged proteins is favored at disulfide bonds and other sites of high hydrogen atom affinity. J Am Chem Soc 121:2857–2862
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Controlled Release Society
About this chapter
Cite this chapter
Leurs, U., Mistarz, U.H., Rand, K.D. (2016). Applications of Mass Spectrometry in Drug Development Science. In: Müllertz, A., Perrie, Y., Rades, T. (eds) Analytical Techniques in the Pharmaceutical Sciences. Advances in Delivery Science and Technology. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-4029-5_7
Download citation
DOI: https://doi.org/10.1007/978-1-4939-4029-5_7
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-4027-1
Online ISBN: 978-1-4939-4029-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)